###begin article-title 0
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Association of CYP1B1 Polymorphisms with Breast Cancer: A Case-Control Study in the Han Population in Ningxia Hui Autonomous Region, P. R. China
###end article-title 0
###begin p 1
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 287 293 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 492 498 488 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 970 976 962 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1088 1094 1080 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 835 841 <span type="species:ncbi:9606">people</span>
Studies investigating possible associations between cytochrome P4501B1 (CYP1B1) polymorphisms and breast cancer risk have been inconsistent. We set out to ascertain whether there might be an association between polymorphisms in exon 2 (codon 119, G-->T) and exon 3 (codon 432, G-->C) of CYP1B1 and breast cancer in a Chinese Han population in the rural region of Ningxia. Using an allele-specific polymerase chain reaction method and direct DNA sequencing, the presence or absence of the two CYP1B1 polymorphisms was investigated. Genotype and allele frequencies were analyzed in breast cancer cases (n = 152) and healthy age-matched controls (n = 156). The odds ratio (OR) of 119G-->T or 432G-->C in breast cancer cases and controls was 3.3 (95% CI: 1.28 to 8.28) and 2.8 (95% CI: 1.04 to 7.51), respectively. In addition, the OR for people with both polymorphisms (119T and 432C) was 4.69 (95% CI: 1.97 to 11.19). Our results suggest that certain polymorphisms in the CYP1B1 gene might increase risk for breast cancer among Han Chinese, perhaps because they influence the efficiency of CYP1B1 bio-transformation of oestrogens or pro-carcinogens into DNA-reactive electrophiles that may act as cancer-initiating agents.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 332 339 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1/2</italic>
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-bmi-2010-021">1</xref>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-bmi-2010-021">2</xref>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-bmi-2010-021">3</xref>
###xml 524 530 524 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 593 595 593 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OH</italic>
###xml 597 598 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 733 734 733 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-bmi-2010-021">4</xref>
###xml 735 736 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-bmi-2010-021">7</xref>
###xml 755 761 755 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 785 787 785 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OH</italic>
###xml 789 790 789 790 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 875 876 875 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-bmi-2010-021">8</xref>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-bmi-2010-021">10</xref>
###xml 886 888 886 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OH</italic>
###xml 889 890 889 890 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1061 1062 1058 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1076 1078 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-bmi-2010-021">11</xref>
###xml 171 176 <span type="species:ncbi:9606">women</span>
Breast cancer remains a major cause of morbidity and mortality worldwide with incidence rates ranging from 27/100,000 in Asian countries to 97/100,000 among US Causcasian women, but its aetiology remains unclear. Only a small proportion of cases (<10%) may be due to germline mutations in highly-penetrant susceptibility genes e.g. BRCA1/2.1 The majority of cases are sporadic and their causes are obscure, although cumulative hormonal exposure and environmental influences appear to be risk factors.2,3 Cytochrome P4501B1 (CYP1B1) catalyzes the formation of genotoxic 4-hydroxy oestradiol (4-OH E2), and bio-activates environmental pro-carcinogens [e.g. polycyclic aromatic hydrocarbons (PAHs), heterocyclic aromatic amines (HAAs)].4-7 The expression of CYP1B1 and the formation of 4-OH E2 have been associated with oestrogen-related tumours in multiple tissues and species.8-10 The 4-OHE2 catechol metabolite has the highest carcinogenic as well as oestrogenic activity and is found in higher quantities in breast cancer tissue than other 17beta-oestradiol (E2) metabolites.11
###end p 3
###begin p 4
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-bmi-2010-021">12</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-bmi-2010-021">14</xref>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-bmi-2010-021">15</xref>
###xml 290 296 290 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 446 447 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-bmi-2010-021">6</xref>
###xml 498 504 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 141 146 <span type="species:ncbi:9606">human</span>
CYP1B1 is genetically polymorphic, and sequence variations in the gene may be related to risk of breast cancer in some populations.12-14 The human CYP1B1 gene, located at the 2p21-22 region, consists of three exons, one of which is noncoding, and two introns.15 Two common polymorphisms of CYP1B1 in exon 2 (codon 119, Ala-->Ser) and exon 3 (codon 432, Val-->Leu) encode the heme-binding domain; variant alleles probably exhibit altered activity.6 Therefore, genetic polymorphisms at loci encoding CYP1B1 may explain why individuals vary in their susceptibility to the carcinogenic effects of environmental chemicals.
###end p 4
###begin p 5
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-bmi-2010-021">12</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-bmi-2010-021">14</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-bmi-2010-021">16</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-bmi-2010-021">19</xref>
###xml 434 440 434 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 535 543 <span type="species:ncbi:9606">patients</span>
Studies reporting the association between CYP1B1 polymorphisms and breast cancer have involved different populations but, have given rise to often inconsistent and/or contradicting findings even within the same ethnic groups.12-14,16-19 We undertook a case-control study of a genetically-uniform population of Han Chinese in the Ningxia Hui Autonomous Region of P. R. China in which genotype and allele frequency associations between CYP1B1 polymorphisms [in exon 2 (codon 119, G-->T) and exon 3 (codon 432, G-->C)] with breast cancer patients and healthy controls were determined. Our results point to an association between these two polymorphisms and breast cancer in this study population.
###end p 5
###begin title 6
Material and Methods
###end title 6
###begin title 7
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants
###end title 7
###begin p 8
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 173 185 <span type="species:ncbi:9606">participants</span>
From May 2005 to June 2006, a total of 152 sporadic breast cancer patients and 156 healthy controls were recruited at Affiliated Hospital of Ningxia Medical University. All participants provided written informed consent before participating in the study. This research programme was approved by the local ethics approvals board at Ningxia Medical University.
###end p 8
###begin p 9
###xml 439 447 <span type="species:ncbi:9606">patients</span>
###xml 501 513 <span type="species:ncbi:9606">participants</span>
The 152 breast cancer cases were verified by histopathology with a single pathologist. A cohort of 156 controls confirmed to be free of any cancer based on a health examination were randomly matched to the breast cancer arm of the study, with an age difference that was no greater than 5 years (y). The status for oestrogen receptor (ER) and progesterone receptor (PR) was also collected. The controls were not related in any way with the patients and they had no family history of breast cancer. All participants were long-term residents of Ningxia who had no prior history of cancer.
###end p 9
###begin title 10
DNA isolation and analysis of single nucleotide polymorphisms (SNPs)
###end title 10
###begin p 11
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-bmi-2010-021">Table 1</xref>
Blood samples (3-5 ml) were collected in Vacutainer tubes containing ethylenediaminetetraacetic acid (EDTA). Genomic DNA was extracted using standard phenol/chloroform methods. The sequences of primers for polymerase chain reaction (PCR) at each locus were synthesized by SBS-Biology (Beijing) and are listed in Table 1.
###end p 11
###begin title 12
Polymerase chain reaction (PCR) amplification
###end title 12
###begin p 13
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 244 245 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 324 327 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
Genotyping assays for the two SNPs for CYP1B1 were conducted using allele-specific (AS) PCR methods in a Biometra T Gradient Thermocycler (Bio-Rad Laboratories). Each PCR mixture (25 mul) contained 10 ng DNA, 1 x PCR buffer with 1.5 mmol/L MgCl2, 0.16 mmol/L of each dNTP, 0.4 mumol/L of each primer, and 1 unit of Hotstart Taq DNA polymerase (SBS-Biology). The reaction mixture was initially denatured at 95 degreesC for 5 min, followed by 30 cycles at 94 degreesC for 30 sec, 60 degreesC for 30 sec, and 72 degreesC for 45 sec. The PCR was completed by a final extension cycle at 72 degreesC for 5 min. The DNA fragments were then separated and visualized by electrophoresis on 2% agarose gels containing ethidium bromide.
###end p 13
###begin title 14
Statistical analysis
###end title 14
###begin p 15
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 103 104 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 297 303 295 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 345 346 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 393 399 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
We determined whether CYP1B1 genotype frequencies were in Hardy-Weinberg equilibrium using standard chi2-statistics. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using SPSS (Version 11.5; Chicago, IL., USA). ORs were used to measure the strength of the association between CYP1B1 genotypes and breast cancer risk. The chi2 test was used to compare the distributions of CYP1B1 alleles and genotypes in cases and controls.
###end p 15
###begin title 16
Results
###end title 16
###begin p 17
###xml 18 26 <span type="species:ncbi:9606">patients</span>
###xml 296 303 <span type="species:ncbi:9606">patient</span>
The breast cancer patients had an age range between 28 y and 75 y, with a mean (M) and standard deviation (SD) of 52.27 (10.28) y. The control cohort had an age range between 30 y and 70 y, with a M (SD) of 52.69 (11.25) y. There was no significant difference in the age distribution between the patient and control arms of the study.
###end p 17
###begin p 18
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 80 90 80 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-bmi-2010-021">Figures 1A</xref>
###xml 142 158 142 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-bmi-2010-021">Figures 1C and D</xref>
###xml 212 218 212 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 434 441 434 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-bmi-2010-021">Fig. 1A</xref>
###xml 474 480 474 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 686 693 686 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-bmi-2010-021">Fig. 1B</xref>
###xml 791 797 789 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 914 921 912 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-bmi-2010-021">Fig. 1C</xref>
###xml 1024 1030 1020 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1147 1154 1143 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-bmi-2010-021">Fig. 1D</xref>
Representative samples for genotyping codons 119 and 432 of CYP1B1 are shown in Figures 1A and B, and typical sequencing results are shown in Figures 1C and D. In tests to determine the genotypes of codon 119 in CYP1B1, the appearance of only the "a" band was identified with GG based on DNA fragment size, the appearance of both "a" and "b" bands was identified with GT, and the appearance of only a "b" band was identified with TT (Fig. 1A). For genotypes of codon 432 of CYP1B1, the appearance of only the "a" band corresponded to GG based on DNA fragment size, the appearance of both "a" and "b" bands corresponded to GC, and the appearance of only the "b" band corresponded to CC (Fig. 1B). Reverse sequence analysis of DNA revealed a heterozygous G-->T transition at nucleotide 335 of CYP1B1 (GenBank accession No. rs1056827), which results in a substitution of alanine (Ala) at codon 119 by a serine (Ser) (Fig. 1C). Direct sequence analysis of DNA also revealed a heterozygous G-->C transition at nucleotide 1294 of CYP1B1 (GenBank accession No. rs1056836), which causes a substitution of the valine (Val) at codon 432 by a leucine (Leu) (Fig. 1D).
###end p 18
###begin p 19
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 112 119 112 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-bmi-2010-021">Table 2</xref>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 557 564 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-bmi-2010-021">Table 3</xref>
###xml 658 659 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 761 762 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1098 1099 1098 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1110 1117 1110 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-bmi-2010-021">Table 3</xref>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
We compared the distribution frequencies of the two SNPs for CYP1B1 in breast cancer patients and the controls (Table 2). The frequencies of the G and T alleles on codon 119T/G of CYP1B1 differed significantly between the two cohorts (P = 0.000) with an OR of 2.20 (95% CI: 1.49 to 3.26). The frequencies of G and C alleles on codon 432C/G of CYP1B1 also showed significant differences between the two cohorts (P = 0.003), with an OR of 1.97 (95% CI: 1.25 to 3.11). The genotype frequencies at codons 119 and 432 for all subjects in this study are shown in Table 3. The distributions of the two polymorphisms were consistent with Hardy-Weinberg equilibrium (P > 0.05). There were significant differences in the GG, GT, and TT genotypes between the two cohorts (P = 0.001). The risk of breast cancer in individuals with genotypes of the homozygous TT mutation and heterozygous GT mutation was increased 3.26- and 2.32-fold, respectively, compared to the risk in individuals with the wild-type GG. There were significant differences in frequencies of the genotype GG, GC, CC between the two cohorts (P = 0.038) (Table 3). The risk of breast cancer in individuals with the homozygous CC mutation and the heterozygous GC mutation was increased 2.79- and 1.69-fold, respectively, compared to the risk in individuals with the wild-type GG.
###end p 19
###begin p 20
###xml 110 117 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-bmi-2010-021">Table 4</xref>
###xml 271 277 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-bmi-2010-021">20</xref>
We analyzed the effect of the combined 119/432 genotypes on breast cancer risk in the Ningxia Han population (Table 4). In our study, we observed individuals with the genotype of 119G/G-432C/G, 119T/T-432C/G, 119G/T-432C/C, or 119G/T-432G/G. Therefore it would seem that CYP1B1 codons 119 and 432 are not in linkage disequilibrium. The OR for individuals possessing both 119T and 432C was nearly five times the OR for those possessing 119G/G-432G/G. No associations were found between these two variations and with ER or PR status.20
###end p 20
###begin title 21
Discussion
###end title 21
###begin p 22
###xml 203 209 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-bmi-2010-021">12</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-bmi-2010-021">14</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-bmi-2010-021">16</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-bmi-2010-021">19</xref>
###xml 410 416 410 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 500 506 500 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">119T/T</italic>
###xml 511 514 511 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/T</italic>
###xml 564 565 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 802 808 802 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 592 600 <span type="species:ncbi:9606">patients</span>
###xml 617 629 <span type="species:ncbi:9606">participants</span>
###xml 666 674 <span type="species:ncbi:9606">patients</span>
###xml 687 699 <span type="species:ncbi:9606">participants</span>
Individual susceptibility to cancer is likely to be influenced by the genotype for enzymes involved in the activation or detoxification of carcinogens. Polymorphic alleles of key candidate genes such as CYP1B1, which are involved in oestrogen and xenobiotic metabolism, may contribute to the different risks of breast cancer observed for different populations.12-14,16-19 In the present study, we investigated CYP1B1 polymorphisms in a Ningxia Han Chinese population, and observed that the genotypes 119T/T and G/T are present at a significantly higher frequency (P = 0.001) in breast cancer patients than in control participants. A difference between breast cancer patients and healthy participants was also found in the allelic distributions of codon 432. The combination of the two polymorphisms of CYP1B1 investigated [in exon 2 (codon 119, G-->T) and exon 3 (codon 432, G-->C)] further increases the risk of breast cancer in this Ningxia Han (China) ethnic group.
###end p 22
###begin p 23
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 210 216 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 284 286 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-bmi-2010-021">21</xref>
###xml 339 345 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 512 514 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-bmi-2010-021">21</xref>
###xml 526 532 518 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 622 628 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 942 944 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-bmi-2010-021">22</xref>
###xml 945 947 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-bmi-2010-021">24</xref>
###xml 853 858 <span type="species:ncbi:9606">women</span>
###xml 936 941 <span type="species:ncbi:9606">women</span>
Previous studies on the association between CYP1B1 codon 119(G-->T) and codon 432(G-->C) and breast cancer in different populations have often given rise to conflicting or contradicting results. Our results on CYP1B1 codon 119(G-->T) confirm those of a study in a Japanese population.21 Nevertheless, we measured higher frequencies of the CYP1B1 codon 119(G-->T) "T" allele among controls (0.16) and cases (0.29) in the Ningxia Han than were reported among controls (0.12) and cases (0.16) in the Japanese study.21 Therefore, CYP1B1 codon 119(G-->T), which is thought to participate in the substrate recognition site 1 of CYP1B1 protein, is significantly associated with breast cancer in both the Ningxia Han (China) population and the Japanese. This contradicts the protective effect reported for this polymorphism in studies carried out among Chinese women in Shanghai, Caucasian and African in U.S. (Nashville, Tennessee) and Polish women.22-24
###end p 23
###begin p 24
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-bmi-2010-021">12</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-bmi-2010-021">25</xref>
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 250 253 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Val</italic>
###xml 254 257 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Val</italic>
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Val</italic>
###xml 266 269 266 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</italic>
###xml 487 490 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Val</italic>
###xml 491 494 491 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Val</italic>
###xml 499 502 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Val</italic>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</italic>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-bmi-2010-021">26</xref>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 741 743 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-bmi-2010-021">24</xref>
###xml 744 746 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-bmi-2010-021">26</xref>
###xml 1056 1058 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-bmi-2010-021">26</xref>
###xml 1200 1207 1198 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Val/Leu</italic>
###xml 1330 1332 1328 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-bmi-2010-021">18</xref>
###xml 1359 1366 1357 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu/Leu</italic>
###xml 1549 1555 1547 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1794 1796 1790 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-bmi-2010-021">19</xref>
###xml 1797 1799 1793 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-bmi-2010-021">20</xref>
###xml 1800 1802 1796 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-bmi-2010-021">22</xref>
###xml 1803 1805 1799 1801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-bmi-2010-021">27</xref>
###xml 1806 1808 1802 1804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-bmi-2010-021">28</xref>
###xml 1859 1873 1855 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1 Val/Leu</italic>
###xml 2138 2139 2134 2135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2159 2161 2155 2157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-bmi-2010-021">13</xref>
###xml 1344 1349 <span type="species:ncbi:9606">women</span>
###xml 1995 2000 <span type="species:ncbi:9606">women</span>
The valine substitution is reported to be present at an allele frequency of 0.43 in Caucasians, 0.75 in African-Americans and 0.23 in Asians.12,25 No association between the CYP1B1 Val432Leu polymorphism and breast cancer was observed in Asians (for Val/Val and Val/Leu combined, OR = 1.0, 95% CI: 0.8, 1.2). An inverse association was observed in a population of mixed/African origin (OR = 0.8, 95% CI: 0.7, 0.9). The pooled analysis suggested a possible association in Caucasians (for Val/Val and Val/Leu combined, OR = 1.5, 95% CI: 1.1, 2.1), with effect modification across age categories.26 Our finding of an association between CYP1B1 codon 432 (G-->C) and breast cancer is consistent with the results of several studies in Caucasians.24,26 In our study, the risk of breast cancer in individuals with the homozygous CC mutation or the heterozygous GC mutation was increased 2.79 (95% CI: 1.04 to 7.51)- and 1.69 (95% CI: 0.92 to 3.08)-fold, respectively, compared to that of individuals with wild-type GG. In one study of Caucasians, Listgarten et al26 found that the homozygous Leu/Leu mutation conferred a 3.30-fold higher risk of breast cancer (95% CI: 1.76 to 6.19), while the heterozygous Val/Leu genotype was associated with a 2.15-fold higher risk (95% CI: 1.31-3.52). In a study of a Shanghai population, Zheng et al18 found that women with the Leu/Leu genotype had a 2.3-fold [95% CI, 1.2-4.5] higher risk of breast cancer. Our study in the Ningxia Han population confirms these results, although we measured lower frequencies of the CYP1B1 codon 432(G-->C) "C" allele among controls (0.11) and cases (0.19) compared to those reported among controls (0.46) and cases (0.53) in the Shanghai Han population, respectively. Some studies in Caucasian populations and Asian populations19,20,22,27,28 have found no significant association between the CYP1B1 Val/Leu genotype and breast cancer risk. However, others have found a significant increase in the breast cancer risk for smoking women in a Finnish population (OR = 2.6, 95% CI 1.07-6.46), especially for smokers homozygous for the Leu allele (OR = 5.1, 95% CI 1.30-19.89, P for trend = 0.005).13
###end p 24
###begin title 25
Conclusion
###end title 25
###begin p 26
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 827 835 823 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 903 909 899 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 950 952 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-bmi-2010-021">28</xref>
###xml 953 955 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-bmi-2010-021">29</xref>
###xml 482 487 <span type="species:ncbi:9606">women</span>
###xml 930 935 <span type="species:ncbi:9606">human</span>
Certain genotypes may contribute to variation in risk for breast cancer observed in different populations or ethnic groups. To evaluate this in a rural Ningxia Han population of P. R. China, we analysed the association between CYP1B1 codon 119 (Ala-->Ser) and codon 432 (Val-->Leu) and risk of breast cancer. Our results show that the risk of breast cancer increases significantly (OR = 4.69, 95% CI 1.97-11.9) proportional to the number of variant alleles individuals possess. Han women living in the Ningxia province are relatively homogeneous in ethnic background, therefore eliminating some confounding effects. On the other hand, our study investigates a relatively small sample size in a case-control setting, which may make our risk estimates unstable. Nevertheless, our results are consistent with recent findings from in vitro and animal experiments implicating a potentially important role of CYP1B1 in the aetiology of human breast cancer.28,29
###end p 26
###begin p 27
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-bmi-2010-021">30</xref>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Other factors such as the expressed profile of ER splice variants may play a hitherto under-recognised role in the modulation of breast cancer risk.30 However, we conclude that the functional polymorphism of CYP1B1 may be a risk factor for breast cancer in the Ningxia Han population of China, and in at least some other populations. Further investigations involving larger sample sizes and other ethnic populations are needed in order to establish more completely the relationship between these CYP1B1 SNPs and breast cancer risk.
###end p 27
###begin title 28
Abbreviations
###end title 28
###begin p 29
alanine;
###end p 29
###begin p 30
allele-specific polymerase chain reaction;
###end p 30
###begin p 31
confidence interval;
###end p 31
###begin p 32
cytochrome P4501B1;
###end p 32
###begin p 33
17beta-oestradiol;
###end p 33
###begin p 34
ethylenediaminetetraacetic acid;
###end p 34
###begin p 35
oestrogen receptor;
###end p 35
###begin p 36
heterocyclic aromatic amine;
###end p 36
###begin p 37
4-hydroxy oestradiol;
###end p 37
###begin p 38
leucine;
###end p 38
###begin p 39
mean;
###end p 39
###begin p 40
odds ratio;
###end p 40
###begin p 41
polycyclic aromatic hydrocarbon;
###end p 41
###begin p 42
polymerase chain reaction;
###end p 42
###begin p 43
progesterone receptor;
###end p 43
###begin p 44
serine;
###end p 44
###begin p 45
standard deviation;
###end p 45
###begin p 46
single nucleotide polymorphism;
###end p 46
###begin p 47
valine;
###end p 47
###begin p 48
years.
###end p 48
###begin p 49
###xml 0 17 0 17 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Financial Support</bold>
Financial Support
###end p 49
###begin p 50
This research was supported by grants from the National Natural Science Foundation of Ningxia, China (Grant no. NZ0535) and from Ningxia Medical University (Grant no. YY200750).
###end p 50
###begin p 51
###xml 0 19 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests</bold>
Competing Interests
###end p 51
###begin p 52
The authors declare that they have no competing interests.
###end p 52
###begin title 53
References
###end title 53
###begin article-title 54
Genotoxins and the initiation of sporadic breast cancer
###end article-title 54
###begin article-title 55
###xml 91 96 <span type="species:ncbi:302767">Comet</span>
Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and the Comet assay
###end article-title 55
###begin article-title 56
###xml 16 21 <span type="species:ncbi:9606">human</span>
Genotoxicity of human mammary lipid
###end article-title 56
###begin article-title 57
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue
###end article-title 57
###begin article-title 58
Cytochrome P450 enzymes: Novel options for cancer therapeutics
###end article-title 58
###begin article-title 59
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
CYP1B1 expression in prostate is higher in the peripheral than in the transition zone
###end article-title 59
###begin article-title 60
###xml 122 127 <span type="species:ncbi:9606">human</span>
Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate
###end article-title 60
###begin article-title 61
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Expression of cytochrome P450 CYP1B1 in breast cancer
###end article-title 61
###begin article-title 62
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1
###end article-title 62
###begin article-title 63
A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver
###end article-title 63
###begin article-title 64
###xml 44 49 <span type="species:ncbi:9606">human</span>
17beta-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1
###end article-title 64
###begin article-title 65
###xml 97 102 <span type="species:ncbi:9606">women</span>
Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women
###end article-title 65
###begin article-title 66
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1A1</italic>
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population
###end article-title 66
###begin article-title 67
Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race
###end article-title 67
###begin article-title 68
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia
###end article-title 68
###begin article-title 69
###xml 99 104 <span type="species:ncbi:9606">women</span>
Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women
###end article-title 69
###begin article-title 70
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 121 128 <span type="species:ncbi:4097">tobacco</span>
Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-O-methyltransferase and tobacco exposure in breast cancer risk
###end article-title 70
###begin article-title 71
Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer
###end article-title 71
###begin article-title 72
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19</italic>
CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study
###end article-title 72
###begin article-title 73
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Research on Breast Cancer Genetic Susceptibility Associated with CYP1B1 SNPrs1056836, ER and PR in Ningxia Han Population
###end article-title 73
###begin article-title 74
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer
###end article-title 74
###begin article-title 75
###xml 109 114 <span type="species:ncbi:9606">women</span>
Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis
###end article-title 75
###begin article-title 76
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer
###end article-title 76
###begin article-title 77
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 89 94 <span type="species:ncbi:9606">women</span>
Genetic variation of cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women
###end article-title 77
###begin article-title 78
###xml 6 12 6 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls
###end article-title 78
###begin article-title 79
Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms
###end article-title 79
###begin article-title 80
Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review
###end article-title 80
###begin article-title 81
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Association of CYP1B1 polymorphisms and breast cancer risk
###end article-title 81
###begin article-title 82
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study
###end article-title 82
###begin article-title 83
Oestrogen receptor splice variants in the pathogenesis of disease
###end article-title 83
###begin p 84
###xml 0 4 0 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, B</bold>
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 82 83 82 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 205 206 203 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
A, B) Representative samples for the genotyping for codons 119 and 432 of CYP1B1; C) Reverse sequence analysis to reveal a heterozygous G-->T transition to result in substitution of Ala at codon 119; and, D) Direct sequence analysis to reveal a heterozygous G-->C transition to result in substitution of Val at codon 432.
###end p 84
###begin p 85
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
The primer sequences in codons 119 and 432 of CYP1B1.
###end p 85
###begin p 86
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abbreviations:</bold>
Abbreviations: F, forward primer; R, reverse primer.
###end p 86
###begin p 87
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Association of codons 119 and 432 of CYP1B1 allele with breast cancer risk (Han population, Ningxia).
###end p 87
###begin p 88
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Association of codons 119 and 432 of CYP1B1 genotype with breast cancer risk (Han population, Ningxia).
###end p 88
###begin p 89
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Association between combined CYP1B1 119-432 genotypes and breast cancer (Han population, Ningxia).
###end p 89

